Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Gut Bacteria: manipulating the microbiome

It has long been known that gut bacteria affect the way we interact with medicines, but the underlying mechanisms are only just beginning to be understood. The Biotechnology company Symberix is at the forefront of research, developing a drug that reduces the side effects of the chemotherapy drug irinotecan by modulating the gut microbiota. Abi Millar found out more.

Close
Close
Close

Go Top